Uterotrophic activity of bisphenol A in the immature mouse

Bisphenol A (BPA) has been evaluated in eight independent immature mouse ut erotrophic assays using the subcutaneous route of administration, and in a single study employing oral gavage. The dose range covered was from 0.02 mu g to 300 mg/kg BPA and some experiments were supplemented by assessments of uterine hypertrophy and hyperplasia. Pooling of the test data indicates no uterotrophic activity for the chemical. However, in a subset of the subcut aneous injection studies, where control uterine weights were relatively low , significant, but weak, uterotrophic activity was observed over a range of dose levels, but in the complete absence of a dose relationship. In the or al gavage study, no increases in uterine weight were seen, but there were i ncreases in uterine labeling with bromodeoxyuridine at 200-300 mg/kg BPA. T he present study illustrated that when a large number of observations are m ade, a certain level of chance observations may be made, and that surrogate s for an increase in uterine weight do not necessarily enhance assay sensit ivity, albeit such data may complement uterine weight data. The data indica te that reducing control uterine weights may enhance assay sensitivity, but that animal body weight is an imperfect indicator of control uterine weigh t. The data also show that it is possible for individual investigators to b e unable to confirm their own observations. It is concluded that BPA may be weakly uterotrophic to the mouse under specific conditions of test, and in the complete absence of a dose-response relationship to this activity. How ever, overall, we have failed to define BPA as reproducibly active in the i mmature mouse uterotrophic assay, and in that sense, our data are broadly c onsistent with those reported earlier by Coldham et al. (Environ. Health Pe rspect. 105, 734-742, 1997) in 1997 using a similar assay, (C) 2000 Academi c Press.